deltatrials

Anatomic stage iii breast cancer ajcc v8 Trials in Aurora, United States

Conditions / Anatomic stage iii breast cancer ajcc v8 / Aurora, United States

Clinical trials for Anatomic stage iii breast cancer ajcc v8 investigate a range of treatment strategies and patient populations.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID Title Status Phase
NCT04001829 Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer ACTIVE_NOT_RECRUITING
NCT05564377 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial RECRUITING
NCT04001829 Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer ACTIVE_NOT_RECRUITING
NCT05812807 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab RECRUITING PHASE3
NCT02115282 Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic ACTIVE_NOT_RECRUITING
NCT02115282 Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic ACTIVE_NOT_RECRUITING
NCT06058377 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer RECRUITING
NCT04457596 T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial ACTIVE_NOT_RECRUITING PHASE3
NCT02115282 Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic ACTIVE_NOT_RECRUITING
NCT04001829 Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer ACTIVE_NOT_RECRUITING

Related Pages